Carney-Stratakis syndrome: genes and variants
Explore variant evidence for Carney-Stratakis syndrome across 3 analyzed proteins (SDHD, SDHB, SDHC). Linked ClinVar records include 20 pathogenic or likely pathogenic variants, 176 variants of uncertain significance and 18 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Counts refer to the selected disease label.
Data updated 2026-11-05. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Carney-Stratakis syndrome
SDHD: Succinate dehydrogenase [ubiquinone] cytochrome b small subunit, mitochondrial
It provides a membrane-anchoring component of succinate dehydrogenase and is required for normal complex II electron transfer. Germline loss-of-function variants, often showing a parent-of-origin effect, strongly predispose to head-and-neck paragangliomas and pheochromocytomas.
11 ClinVar pathogenic / likely pathogenic and 182 uncertain variants in SDHD have source records linked to Carney-Stratakis syndrome. Association strength is not clinical gene validity.
SDHB: Succinate dehydrogenase [ubiquinone] iron-sulfur subunit, mitochondrial
It transfers electrons from succinate oxidation through iron-sulfur centers toward ubiquinone in mitochondrial complex II. Heterozygous loss-of-function variants strongly predispose to paraganglioma and pheochromocytoma and can also increase renal-tumor and gastrointestinal-stromal-tumor risk.
7 ClinVar pathogenic / likely pathogenic and 11 uncertain variants in SDHB have source records linked to Carney-Stratakis syndrome. Association strength is not clinical gene validity.
SDHC: Succinate dehydrogenase cytochrome b560 subunit, mitochondrial
It anchors succinate dehydrogenase to the inner mitochondrial membrane and helps transfer electrons from the catalytic subunits to ubiquinone. Heterozygous loss-of-function variants predispose to paraganglioma, pheochromocytoma, and some gastrointestinal stromal tumors.
2 ClinVar pathogenic / likely pathogenic and 1 uncertain variants in SDHC have source records linked to Carney-Stratakis syndrome. Association strength is not clinical gene validity.
ClinVar pathogenic and likely pathogenic variants linked to Carney-Stratakis syndrome
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| SDHD H102R | 102 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| SDHC R72C | 72 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| SDHD M1I | 1 | Pathogenic / likely pathogenic (★★) | |
| SDHD H102N | 102 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| SDHD H102L | 102 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| SDHB I127S | 127 | 2Fe-2S ferredoxin-type | Pathogenic / likely pathogenic (★★) |
| SDHB C192R | 192 | 4Fe-4S ferredoxin-type | Pathogenic / likely pathogenic (★★) |
| SDHB P197S | 197 | 4Fe-4S ferredoxin-type | Pathogenic / likely pathogenic (★★) |
| SDHC R72G | 72 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| SDHB R230H | 230 | Pathogenic / likely pathogenic (★★) | |
| SDHB R242H | 242 | Pathogenic / likely pathogenic (★★) | |
| SDHD M1V | 1 | Pathogenic / likely pathogenic (★★) | |
| SDHD G106D | 106 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| SDHD G106V | 106 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| SDHB W200C | 200 | 4Fe-4S ferredoxin-type | Pathogenic / likely pathogenic (★★) |
| SDHB V140F | 140 | Pathogenic / likely pathogenic (★★) | |
| SDHD P81L | 81 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| SDHD G138R | 138 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| SDHD M1T | 1 | Pathogenic / likely pathogenic (★) | |
| SDHD L139R | 139 | Transmembrane | Pathogenic / likely pathogenic (★) |
Uncertain variants prioritized for review in Carney-Stratakis syndrome
| Variant | Position | Protein part | Clinical label | Evidence |
|---|---|---|---|---|
| SDHD G138E | 138 | Transmembrane | Conflicting reports (★) | +6: 2 other pathogenic changes within 3 positions; G138R at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.97 |
Which prediction tools work for Carney-Stratakis syndrome
Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.
- SIFT: 100 out of 100
- MetaLR: 100 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- PolyPhen-2: 99 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MetaSVM: 99 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- AlphaMissense: 88 out of 100
- ESM1b (LLR): 87 out of 100
- CATVariant: 85 out of 100 (learned from overlapping clinical labels, so this is optimistic)
Same protein, different disease
- Pheochromocytoma also has ClinVar records linked to SDHD variants; they fall partly in the same places as the Carney-Stratakis syndrome variants (14 pathogenic / likely pathogenic).
- Paragangliomas with sensorineural hearing loss also has ClinVar records linked to SDHD variants; they fall partly in the same places as the Carney-Stratakis syndrome variants (13 pathogenic / likely pathogenic).
- Cowden syndrome also has ClinVar records linked to SDHD variants; they fall partly in the same places as the Carney-Stratakis syndrome variants (11 pathogenic / likely pathogenic).
- Gastrointestinal stromal tumor also has ClinVar records linked to SDHB variants; they fall mostly in different places as the Carney-Stratakis syndrome variants (53 pathogenic / likely pathogenic).
- Pheochromocytoma/paraganglioma syndrome also has ClinVar records linked to SDHB variants; they fall mostly in different places as the Carney-Stratakis syndrome variants (48 pathogenic / likely pathogenic).
- Pheochromocytoma also has ClinVar records linked to SDHB variants; they fall mostly in different places as the Carney-Stratakis syndrome variants (47 pathogenic / likely pathogenic).
- Inherited phaeochromocytoma and paraganglioma excluding NF1 also has ClinVar records linked to SDHB variants; they fall mostly in different places as the Carney-Stratakis syndrome variants (4 pathogenic / likely pathogenic).
- Gastrointestinal stromal tumor also has ClinVar records linked to SDHC variants; they fall mostly in different places as the Carney-Stratakis syndrome variants (16 pathogenic / likely pathogenic).
- Pheochromocytoma/paraganglioma syndrome also has ClinVar records linked to SDHC variants; they fall mostly in different places as the Carney-Stratakis syndrome variants (16 pathogenic / likely pathogenic).
Diseases related to Carney-Stratakis syndrome
- Pheochromocytoma/paraganglioma syndrome, also linked to SDHB, SDHC and SDHD
- Hereditary pheochromocytoma and paraganglioma, also linked to SDHB, SDHC and SDHD
- Gastrointestinal stromal tumor, also linked to SDHB and SDHC
- Pheochromocytoma, also linked to SDHB and SDHD
- Inherited phaeochromocytoma and paraganglioma excluding NF1, also linked to SDHB and SDHC
- Mitochondrial complex 2 deficiency, nuclear, also linked to SDHB and SDHD
- Cowden syndrome, also linked to SDHD
- Mitochondrial complex II deficiency, nuclear, also linked to SDHD
- Paragangliomas with sensorineural hearing loss, also linked to SDHD
Frequently asked questions
Which genes have records linked to Carney-Stratakis syndrome?
This view contains 3 analyzed proteins: SDHD, SDHB, SDHC. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 20 pathogenic or likely pathogenic variants, 176 variants of uncertain significance and 18 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 1 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 239 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center